摘要
目的:分享我科静脉输液港使用经验,探讨置入式静脉输液港并发症及其原因。方法:回顾性分析我科2011~2017年运用静脉输液港进行乳腺癌化疗患者相关并发症,探讨发病原因及防治方法。结果:乳腺癌化疗患者共130名放置静脉输液港,共发生并发症9例(6.9%),其中3例(2.3%)发生导管相关的血栓,1例(0.8%)导管头移位,1例(0.8%)静脉港座外露,2例(1.5%)导管脱落,2例(1.5%)放置失败。结论:静脉港是安全有效的治疗手段,其并发症发生率较低。无菌原则和医生及护理人员规范的操作可有效的减少并发症发生率。
Objective: To present our experience and clarify the complications of totally implantable venous access ports (TIVAP) and the risk factors for such complications. Methods: To analyze the compli-cations of breast cancer patients in our center who implanted TIVAP for chemotherapy from 2011 to 2017 and to explore the causes and methods of prevention and treatment. Result: There were 130 patients with breast cancer placed TIVAP, Thrombotic complications in 3 cases (2.3%), catheter migration in 1 case (0.8%), base of the port exposure in 1 case (0.8%), pinch-off syndrome in 2 cases (1.5%), failure of placement in 2 cases (1.5%). Conclusion: TIVAP is a safe procedure with lower complications, health care workers involved doctors and nurses should be aware of septic principles, careful insertion and skilled management which would decrease the complication incidence.
出处
《医学诊断》
2021年第1期1-7,共7页
Medical Diagnosis
